| GPNMB confers risk for Parkinson’s disease through interaction with α-synuclein ME Diaz-Ortiz, Y Seo, M Posavi, M Carceles Cordon, E Clark, N Jain, ... Science 377 (6608), eabk0637, 2022 | 78 | 2022 |
| Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration DV Neel, H Basu, G Gunner, MD Bergstresser, RM Giadone, H Chung, ... Neuron 111 (8), 1222-1240. e9, 2023 | 40 | 2023 |
| Molecular Integration in Neurological Diagnosis (MIND) Parkinson's Disease Inception Cohort Study Protocol TF Tropea, W Hartstone, N Amari, D Baum, J Rick, E Suh, H Zhang, ... | 1 | 2024 |
| The Adaptor Protein 2 (AP2) complex modulates habituation and behavioral selection across multiple pathways and time windows RZ Mouret, JP Greenbaum, HM Doll, EM Brody, EL Iacobucci, NC Roland, ... bioRxiv, 2022.05. 20.492863, 2022 | 1 | 2022 |
| Genetic and phenotypic characterization of Parkinson’s disease at the clinic-wide level TF Tropea, W Hartstone, N Amari, D Baum, J Rick, E Suh, H Zhang, ... npj Parkinson's Disease 10 (1), 97, 2024 | | 2024 |
| The adaptor protein 2 (AP2) complex modulates habituation and behavioral selection across multiple pathways and time windows RZ Mouret, JP Greenbaum, HM Doll, EM Brody, EL Iacobucci, NC Roland, ... Iscience 27 (4), 2024 | | 2024 |
| GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders EM Brody, Y Seo, ER Suh, N Amari, WG Hartstone, RT Skrinak, H Zhang, ... Movement Disorders, 2024 | | 2024 |
